Bart Van den Daele | Director, Value & Access
Gilead Sciences

Bart Van den Daele Director, Value & Access - Belgium & Luxembourg, Gilead Sciences With over 20 years in the biopharmaceutical industry, Bart specializes in creating patient access to life-saving treatments. At Gilead Sciences, Bart leads Market Access Strategies to ensure innovative therapies reach patients in need. Drawing on extensive experience in regulatory and public affairs, Bart fosters collaboration to address critical needs in oncology, hematology, infectious diseases and rare diseases, improving outcomes accross the Belux region.